Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment
Clearmind Medicine (US:CMND) Newsfilter·2024-06-28 11:55Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office This latest patent builds upon Clearmind's broa ...